Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > KZR Kezar Life Sciences > Detailed Quotes

KZR Kezar Life Sciences

Watchlist
6.780
-0.050-0.73%
Close  02/07 16:00 ET
High
6.920
Open
6.830
Turnover
2.66M
Low
6.600
Pre Close
6.830
Volume
394.72K
Market Cap
463.60M
P/E(TTM)
Loss
52wk High
18.550
Shares
68.38M
P/E(Static)
Loss
52wk Low
4.305
Float Cap
330.00M
Bid/Ask %
100.00%
Historical High
36.327
Shs Float
48.67M
Volume Ratio
0.78
Historical Low
2.180
Dividend TTM
--
Div Yield TTM
--
P/B
1.64
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.81%
Amplitude
4.69%
Avg Price
6.749
Lot Size
1
Float Cap
330.00M
Bid/Ask %
100.00%
Historical High
36.327
Shs Float
48.67M
Volume Ratio
0.78
Historical Low
2.180
Dividend TTM
--
P/B
1.64
Dividend LFY
--
Turnover Ratio
0.81%
Amplitude
4.69%
Avg Price
6.749
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Kezar Life Sciences, Inc. is a clinical-stage biopharmaceutical company which engages in the development of novel small molecule therapeutics to treat autoimmunity and cancer in South San Francisco and California. Its product pipeline include KZR-616, KZR-261, and KZR-TBD. The company was founded by John Fowler, Christopher J. Kirk, and Jack Taunton on February 20, 2015 and is headquartered in South San Francisco, CA.
CEO: Mr. John Franklin Fowler
Market: NASDAQ
Listing Date: 06/21/2018
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist